Bioresorbable polymers are of great interest to the medical sector as a means of invasive interventions, as they can be subjected to degradation in the human body. The increasing prevalence and incidence of chronic wounds is a considerable source of patient morbidity and financial burden to the healthcare system, a field where tunable biocomposites may facilitate a means of ameliorating persistent factors and warranting proximal tissue remodeling. In the development of a biopolymer medical device, there are several material considerations to note such as physicochemical, biological, and degradation profiles. Polylactic acid (PLA) and polycaprolactone (PCL) have been applied in a plethora of medical fields such as regenerative medicine, cardiovascular implants, pharmaceutical delivery, orthopedic interventions and cancer therapy. Although biocompatible, PLA and PCL have degradation profiles that can extend from months to years. In the development of medical devices, the degradation time of a biomaterial complex should coincide with the regeneration process of proximal tissue to ensure proper remodeling of the tissue. Polydioxanone (PDO) is a synthetic bioresorbable polymer with a short-term degradation profile and weak material strength that has been around since the 1980’s, yet the majority of its medical application has been as suture material. The limited supply and expensive nature of PDO are considerable factors as to why minimal research has been conducted to date. To address these limitations, independent composite formulations of PDO/PLA and PDO/PCL were produced by solvent emulsion. The physicochemical and processing characteristics of all composites were determined by FT-IR, DSC, TGA, rheology and XRD. Polymers were observed to retain their crystalline nature in FTIR and XRD analysis; however, the rheological and thermal properties of PDO were noted as tunable depending on the percent concentration of PLA / PCL respectfully.

1.
Baranwal
,
J.
,
Barse
,
B.
,
Fais
,
A.
,
Delogu
,
G.L.
,
Kumar
,
A.
Biopolymer: A Sustainable Material for Food and Medical Applications
.
Polymers.
2022
Feb 28;
14
(
5
):
983
.
2.
Flórez
,
M.
,
Cazón
,
P.
,
Vázquez
,
M.
Selected Biopolymers’ Processing and Their Applications: A Review
.
Polymers.
2023
Jan 26;
15
(
3
):
641
.
3.
Stanisz
,
M.
,
Klapiszewski
Ł
,
Jesionowski
,
T.
Recent advances in the fabrication and application of biopolymer-based micro-and nanostructures: A comprehensive review
.
Chem Eng J.
2020
Oct 1;
397
:
125409
.
4.
Mtibe
,
A.
,
Motloung
,
M.P.
,
Bandyopadhyay
,
J.
,
Ray
,
S.S.
Synthetic Biopolymers and Their Composites: Advantages and Limitations-An Overview
.
Macromol Rapid Commun.
2021
Aug;
42
(
15
):
e2100130
.
5.
Censi
,
R.
,
Gigliobianco
,
M.R.
,
Casadidio
,
C.
,
Di Martino
,
P.
Hot Melt Extrusion: Highlighting Physicochemical Factors to Be Investigated While Designing and Optimizing a Hot Melt Extrusion Process
.
Pharmaceutics.
2018
Jul 11;
10
(
3
):
89
.
6.
Kosmalska
,
D.
,
Janczak
,
K.
,
Raszkowska-Kaczor
,
A.
,
Stasiek
,
A.
,
Ligor
,
T.
Polylactide as a Substitute for Conventional Polymers—Biopolymer Processing under Varying Extrusion Conditions
.
Environments.
2022
May;
9
(
5
):
57
.
7.
Muehlenfeld
,
C.
,
Thommes
M.
Small-scale twin-screw extrusion-evaluation of continuous split feeding
.
J Pharm Pharmacol.
2014
Dec;
66
(
12
):
1667
76
.
8.
Tsige
,
M.
,
Grest
,
G.S.
Solvent evaporation and interdiffusion in polymer films
.
J Phys Condens Matter.
2005
Nov;
17
(
49
):
S4119
.
9.
Won Yang
,
S.
,
Ho Jang
,
S.
,
Jang
,
M.
,
Hee Kim
,
G.
,
Kwon
,
C.I.
,
Seok Kim
,
K.
, et al
Effect of drawing on mechanical properties, degradation and drug release of dexamethasone-loaded polydioxanone monofilaments
.
Mater Lett.
2022
Dec 1;
328
:
133111
.
10.
Man
,
D.
,
Eskridge
,
C.
,
Niamat
,
R.
,
Strouse
,
B.
,
Bialk
,
P.
,
Kmiec
,
E.
Electrospun fiber membranes enable proliferation of genetically modified cells
.
Int J Nanomedicine.
2013
Feb 27;
8
:
855
64
.
This content is only available via PDF.